- Home
- RGNX vs NQP Comparison
RGNX vs NQP Comparison
Compare RGNX & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- NQP
- Stock Information
- Founded
- RGNX 2008
- NQP 1990
- Country
- RGNX United States
- NQP United States
- Employees
- RGNX N/A
- NQP N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- NQP Trusts Except Educational Religious and Charitable
- Sector
- RGNX Health Care
- NQP Finance
- Exchange
- RGNX Nasdaq
- NQP Nasdaq
- Market Cap
- RGNX 451.1M
- NQP 413.9M
- IPO Year
- RGNX 2015
- NQP N/A
- Fundamental
- Price
- RGNX $9.26
- NQP $11.39
- Analyst Decision
- RGNX Strong Buy
- NQP
- Analyst Count
- RGNX 8
- NQP 0
- Target Price
- RGNX $28.50
- NQP N/A
- AVG Volume (30 Days)
- RGNX 528.4K
- NQP 58.4K
- Earning Date
- RGNX 11-05-2025
- NQP 01-01-0001
- Dividend Yield
- RGNX N/A
- NQP 3.21%
- EPS Growth
- RGNX N/A
- NQP N/A
- EPS
- RGNX N/A
- NQP N/A
- Revenue
- RGNX $155,782,000.00
- NQP N/A
- Revenue This Year
- RGNX $203.27
- NQP N/A
- Revenue Next Year
- RGNX $0.58
- NQP N/A
- P/E Ratio
- RGNX N/A
- NQP N/A
- Revenue Growth
- RGNX 74.95
- NQP N/A
- 52 Week Low
- RGNX $5.04
- NQP $9.65
- 52 Week High
- RGNX $13.48
- NQP $11.89
- Technical
- Relative Strength Index (RSI)
- RGNX 52.58
- NQP 72.93
- Support Level
- RGNX $8.82
- NQP $11.32
- Resistance Level
- RGNX $10.08
- NQP $11.46
- Average True Range (ATR)
- RGNX 0.55
- NQP 0.08
- MACD
- RGNX -0.03
- NQP 0.05
- Stochastic Oscillator
- RGNX 42.66
- NQP 88.10
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.